← Eichor
Condition: Chickenpox Vaccine Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chickenpox Vaccine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Phase 1/Phase 2 · 1 location(s) · Sinovac Biotech Co., Ltd · NCT07400003Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Phase 2 · 1 location(s) · Loyola University · NCT05554068A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rub
Phase 3 · 22 location(s) · GlaxoSmithKline · NCT06855160A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Phase 1/Phase 2 · 1 location(s) · Shanghai Institute Of Biological Products · NCT06932523Second Dose of Varicella Vaccine in Healthy Children
Phase 3 · 5 location(s) · Sinovac (Dalian) Vaccine Technology Co., Ltd. · NCT07475000Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07321808A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine,
Phase 3 · 17 location(s) · GlaxoSmithKline · NCT07406360A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
Phase 3 · 1 location(s) · Beijing Luzhu Biotechnology Co., Ltd. · NCT06088745A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Heal
Phase 3 · 6 location(s) · GlaxoSmithKline · NCT06806137A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Chil
Phase 3 · 1 location(s) · GC Biopharma Corp · NCT07054099A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to
Phase 3 · 97 location(s) · GlaxoSmithKline · NCT06740630Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
Phase N/A · 1 location(s) · University of Alberta · NCT05923970A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population A
Phase 4 · 8 location(s) · GlaxoSmithKline · NCT07502560A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Phase 3 · 46 location(s) · GlaxoSmithKline · NCT06693895Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
Phase 4 · 2 location(s) · Tor Biering-Sørensen · NCT07485283Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
Phase 1 · 2 location(s) · Aribio Lab Co., Ltd. · NCT06137755Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated i
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07047053Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
Phase 1 · 1 location(s) · Guangzhou Patronus Biotech Co., Ltd. · NCT06874842Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Tha
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05580458A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney
Phase 1/Phase 2 · 31 location(s) · GlaxoSmithKline · NCT04006808Reduced Vaccine Response to HZ/su in SLE
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT07636044Shingrix in Renal Transplant Recipients
Phase 3 · 4 location(s) · University of Colorado, Denver · NCT04128189Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
Phase N/A · 1 location(s) · Jiangsu Province Centers for Disease Control and Prevention · NCT07585370
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.